73 results
8-K
ANIX
Anixa Biosciences Inc
24 Mar 21
Entry into a Material Definitive Agreement
4:28pm
share (“Common Stock”), in an underwritten, firm-commitment public offering pursuant to an effective registration statement on Form S-3 (File No. 333
424B5
ANIX
Anixa Biosciences Inc
24 Mar 21
Prospectus supplement for primary offering
4:15pm
reported sale price of the common stock on the Nasdaq Capital Market was $6.97 per share.
The offering is being underwritten on a firm commitment basis
FWP
kosq40gyd0 iq8sh
22 Mar 21
Free writing prospectus
9:53pm
FWP
1l1g6s79bx8c50
22 Mar 21
Free writing prospectus
5:25pm
424B5
bwgcu0bgl490p47rr2
22 Mar 21
Prospectus supplement for primary offering
5:16pm
8-K
EX-3.2
gjngj3ixsqyx4p6t
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:41pm